Toho University Omori Medical Center

Ōta-ku, Tokyo 143-8541

1 studies enrolling now · 7 studies all time

What they study most

ALS, Amyotrophic Lateral Sclerosis (ALS), Antiphospholipid Syndrome (APS), Behçet's Syndrome (BS), Bullous Pemphigoid (BP), Chronic Heart Failure With Preserved Ejection Fraction, Churg-Strauss Syndrome, Dermatomyositis (DM), Eosinophilic Granulomatosis With Polyangiitis, Heart Failure, Immune Thrombocytopenia (ITP), Immune-mediated Necrotizing Myopathy (IMNM)

Studies at this site

• Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) — Recruiting now
• Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
• Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis — Running, not enrolling
• Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
• Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% — Completed
• Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF — Completed